STOCK TITAN

Hexo Corp Stock Price, News & Analysis

HEXO Nasdaq

Welcome to our dedicated page for Hexo news (Ticker: HEXO), a resource for investors and traders seeking the latest updates and insights on Hexo stock.

HEXO Corp (HEXO) is a Health Canada-licensed leader in medical marijuana production, recognized for advanced cultivation methods and pharmaceutical-grade quality standards. This news hub provides investors and industry observers with essential updates on corporate milestones, regulatory compliance, and market developments.

Access timely reports on earnings announcements, facility expansions, and strategic partnerships that shape HEXO's position in the cannabis sector. Track innovations in product development and cultivation technologies through verified press releases and objective analysis.

Key coverage areas span financial results, regulatory updates, production capacity changes, and research initiatives. All content undergoes rigorous verification to ensure alignment with Health Canada's ACMPR framework and financial reporting standards.

Bookmark this page for direct access to HEXO's official communications, including material change reports and partnership announcements. Combine these updates with our historical data repository for comprehensive analysis of the company's evolving market strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.33%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.61%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.38%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.72%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.55%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.67%
Tags
none
-
Rhea-AI Summary

HEXO Corp. has entered into a definitive arrangement agreement with Tilray Brands, Inc. to facilitate the acquisition of HEXO Shares. Under this arrangement, HEXO Shareholders will receive 0.4352 Tilray Shares for each HEXO Share, equating to a purchase price of US$1.25 per HEXO Share based on recent trading averages. The agreement is subject to approval from HEXO Shareholders and regulatory bodies. In parallel, a Waiver and Amendment Agreement has been established, allowing HEXO to meet its financial obligations by modifying existing covenants. This arrangement aims to address HEXO's financial difficulties and was supported by a special committee from HEXO's Board, emphasizing its necessity for future viability. The special meeting for shareholder voting is expected to occur before June 22, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.83%
Tags
News
Rhea-AI Summary

HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) reported Q2 FY23 results, achieving a positive net income of $0.7 million, marking its first-ever profit. Adjusted gross margins improved from 40% to 45%, with net revenues declining 32% to $24.2 million compared to Q1 FY23 and down 57% from Q2 FY22 due to increased competition and pricing pressure. Total operating expenses remained flat at $23.8 million, significantly lower than the previous year, primarily due to impairment charges in FY22. The company generated $5.3 million in cash from operations and paid off $40.7 million in debt. Management emphasizes a focus on profitability despite overall revenue challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.22%
Tags

FAQ

What is the market cap of Hexo (HEXO)?

The market cap of Hexo (HEXO) is approximately 31.2M.
Hexo Corp

Nasdaq:HEXO

HEXO Rankings

HEXO Stock Data

31.24M
42.86M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Ottawa